SGHT (Sight Sciences, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SGHT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Kashif Rashid | Chief Legal Officer | A | — | — |
| 2026-07-06 | Brenton Taylor | EVP, Operations & R&D | Sell | — | — |
| 2026-07-06 | Alison Bauerlein | Chief Operating Officer | Sell | — | — |
| 2026-07-06 | James Rodberg | Chief Financial Officer | Sell | — | — |
| 2026-07-06 | JEREMY B. HAYDEN | Chief Legal Officer | Sell | — | — |
| 2026-07-06 | Paul Badawi | President and CEO | Sell | — | — |
| 2026-07-06 | David Badawi | Chief Technology Officer | Sell | — | — |
| 2026-06-11 | Staffan Encrantz | Director | Buy | — | — |
| 2026-06-05 | Gerhard F Burbach | Director | A | — | — |
| 2026-06-05 | Donald Zurbay | Director | A | — | — |
| 2026-06-05 | Tamara Fountain | Director | A | — | — |
| 2026-06-05 | Catherine Mazzacco | Director | A | — | — |
| 2026-06-05 | Staffan Encrantz | Director | A | — | — |
| 2026-05-19 | Alison Bauerlein | Chief Operating Officer | Sell | — | — |
| 2026-04-09 | James Rodberg | Chief Financial Officer | Sell | — | — |
| 2026-04-09 | JEREMY B. HAYDEN | Chief Legal Officer | Sell | — | — |
| 2026-04-03 | Paul Badawi | President and CEO | Sell | — | — |
| 2026-04-03 | David Badawi | Chief Technology Officer | Sell | — | — |
| 2026-04-03 | Alison Bauerlein | Chief Operating Officer | Sell | — | — |
| 2026-04-03 | Brenton Taylor | EVP, Operations & R&D | Sell | — | — |
| 2026-02-23 | David Badawi | Chief Technology Officer | M | — | — |
| 2026-02-05 | James Rodberg | Chief Financial Officer | A | — | — |
| 2026-02-05 | Paul Badawi | President and CEO | A | — | — |
| 2026-02-05 | David Badawi | Chief Technology Officer | A | — | — |
| 2026-02-05 | Brenton Taylor | EVP, Operations & R&D | A | — | — |
| 2026-02-05 | JEREMY B. HAYDEN | Chief Legal Officer | A | — | — |
| 2026-02-05 | Alison Bauerlein | Chief Operating Officer | A | — | — |
| 2026-01-21 | JEREMY B. HAYDEN | Chief Legal Officer | Sell | — | — |
| 2026-01-21 | James Rodberg | Chief Financial Officer | Sell | — | — |
| 2026-01-21 | Paul Badawi | President and CEO | Sell | — | — |
| 2026-01-21 | David Badawi | Chief Technology Officer | Sell | — | — |
| 2026-01-06 | Brenton Taylor | EVP, Operations & R&D | Sell | — | — |
| 2026-01-06 | James Rodberg | Chief Financial Officer | Sell | — | — |
| 2026-01-06 | JEREMY B. HAYDEN | Chief Legal Officer | Sell | — | — |
| 2026-01-06 | David Badawi | Chief Technology Officer | Sell | — | — |
| 2026-01-06 | Alison Bauerlein | Chief Operating Officer | Sell | — | — |
| 2026-01-06 | Paul Badawi | President and CEO | Sell | — | — |
| 2025-12-30 | David Badawi | Chief Technology Officer | M | — | — |
| 2025-12-30 | David Badawi | Chief Technology Officer | M | — | — |
| 2025-12-18 | Staffan Encrantz | Director | Buy | — | — |
| 2025-12-03 | James Rodberg | Chief Financial Officer | Sell | — | — |
| 2025-11-26 | JEREMY B. HAYDEN | Chief Legal Officer | MIXED | — | — |
| 2025-11-18 | Brenton Taylor | EVP, Operations & R&D | Sell | — | — |
| 2025-11-14 | JEREMY B. HAYDEN | Chief Legal Officer | MIXED | — | — |
| 2025-11-13 | James Rodberg | Chief Financial Officer | A | — | — |
| 2025-11-13 | Alison Bauerlein | Chief Operating Officer | A | — | — |
| 2025-10-08 | Brenton Taylor | EVP, Operations & R&D | Sell | — | — |
| 2025-10-03 | David Badawi | Chief Technology Officer | Sell | — | — |
| 2025-10-03 | Paul Badawi | President and CEO | Sell | — | — |
| 2025-10-03 | JEREMY B. HAYDEN | Chief Legal Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 6,521,203 | — |
| — | President and CEO | 6,122,472 | — |
| — | 10%+ Owner | 4,776,232 | — |
| — | 10%+ Owner | 3,000,000 | — |
| — | 10%+ Owner | 2,669,530 | — |
| — | Chief Financial Officer | 2,635,818 | — |
| — | Director | 2,358,224 | — |
| — | Chief Technology Officer | 1,982,872 | — |
| — | Chief Commercial Officer | 832,293 | — |
| — | Chief Operating Officer | 664,709 | — |
| — | Chief Legal Officer | 357,037 | — |
| — | EVP, Operations & R&D | 264,978 | — |
| — | Chief Operating Officer | 254,826 | — |
| — | Chief Financial Officer | 224,037 | — |
| — | Director | 193,613 | — |
| — | Chief Legal Officer | 181,818 | — |
| — | 10%+ Owner | 175,986 | — |
| — | Director | 175,352 | — |
| — | EVP, Research & Development | 167,767 | — |
| — | Director | 123,207 | — |
| — | Director | 109,650 | — |
| — | Director | 106,768 | — |
| — | Director | 79,040 | — |
| — | Director | 11,940 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SGHT quote page; the site-wide leaderboard is on the insider transactions hub.